70 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial. |
Eisterer W, De Vries A, Öfner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J |
Anticancer research. 2014 Nov 4. pii: 34/11/6767 |
PMID: 25368289 |
Factors influencing the time to development of brain metastases in breast cancer. |
Fromm S, Bartsch R, Rudas M, de Vries A, Wenzel C, Steger GG, Zielinski CC, Poetter R, Dieckmann K |
Breast (Edinburgh, Scotland). 2008 May 19. pii: S0960-9776(08)00102-1. doi: 10.1016/j.breast.2008.03.008 |
PMID: 18486473 |
Analysis of risk factors predicting time to development of brain metastases. |
Knauer M, Rottenfusser A, Bartsch R, Dieckmann K, Wenzel C, Fromm S, Eiter H, Steger GG, Zielinski CC, de Vries A |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.1076 |
PMID: 27951067 |
Neoadjuvant chemoradiation therapy with capecitabine (X) plus cetuximab (C), and external beam radiotherapy (RT) in locally advanced rectal cancer (LARC): ABCSG trial R03. |
Eisterer WM, De Vries A, Oefner D, Greil R, Rabl H, Tschmelitsch J, Schmid R, Kapp K, Zehentmayr F, Thaler J |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.4109 |
PMID: 27961175 |
Recurrently affected genes in juvenile myelomonocytic leukaemia. |
Obenauer JC, Kavelaars FG, Sanders MA, de Vries ACH, de Haas V, Beverloo HB, De Moerloose B, Lammens T, Dworzak M, Hoogenboezem RM, Valk PJM, Touw IP, van den Heuvel-Eibrink MM |
British journal of haematology. 2017 May 9. doi: 10.1111/bjh.14737 |
PMID: 28485469 |
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study. |
Eisterer W, Piringer G, DE Vries A, Öfner D, Greil R, Tschmelitsch J, Samonigg H, Sölkner L, Gnant M, Thaler J |
Anticancer research. 2017 May 6. pii: 37/5/2683. doi: 10.21873/anticanres.11617 |
PMID: 28476845 |
Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial. |
Keil F, Hartl M, Altorjai G, Berghold A, Riedl R, Pecherstorfer M, Mayrbäurl B, De Vries A, Schuster J, Hackl J, Füreder T, Melchardt T, Burian M, Greil R |
European journal of cancer (Oxford, England : 1990). 2021 May 19. pii: S0959-8049(21)00218-5. doi: 10.1016/j.ejca.2021.03.051 |
PMID: 34022697 |
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Mo After a Diagnosis of COVID-19. |
Duivenvoorden R, Vart P, Noordzij M, Soares Dos Santos AC, Zulkarnaev AB, Franssen CFM, Kuypers D, Demir E, Rahimzadeh H, Kerschbaum J, Jager KJ, Turkmen K, Hemmelder MH, Schouten M, Rodríguez-Ferrero ML, Crespo M, Gansevoort RT, Hilbrands LB, van der Net JB, Essig M, du Buf-Vereijken PWG, van Ginneken B, Maas N, Vogt L, van Jaarsveld BC, Bemelman FJ, Klingenberg-Salahova F, Heenan-Vos F, Vervloet MG, Nurmohamed A, Abramowicz D, Verhofstede S, Maoujoud O, Malfait T, Fialova J, Melilli E, Favà A, Cruzado JM, Montero Perez N, Lips J, Krepel H, Adilovic H, Hengst M, Konings C, Rydzewski A, Braconnier P, Weis D, Gellert R, Oliveira J, Alferes DG, Radulescu D, Zakharova EV, Ambuehl PM, Guidotti R, Walker A, Lepeytre F, Rabaté C, Rostoker G, Marques S, Azasevac T, Strazmester Majstorovic G, Katicic D, Ten Dam M, Krüger T, Brzosko S, Liakopoulos V, Zanen AL, Logtenberg SJJ, Fricke L, Kuryata O, Slebe JJP, Abd ElHafeez S, Kemlin D, van de Wetering J, Reinders MEJ, Hesselink DA, Kal-van Gestel J, Eiselt J, Kielberger L, El-Wakil HS, Verhoeven M, Logan I, Canal C, Facundo C, Ramos AM, Debska-Slizien A, Veldhuizen NMH, Tigka E, Polyzou Konsta MA, Panagoutsos S, Mallamaci F, Postorino A, Cambareri F, Matceac I, Nistor I, Covic A, Groeneveld JHM, Jousma J, van Buren M, Diekmann F, Oppenheimer F, Blasco M, Assis Pereira T, Arias-Cabrales C, Llinàs-Mallol L, Buxeda A, Tàrrega CB, Redondo-Pachon D, Jimenez MDA, Mendoza-Valderrey A, Martins AC, Mateus C, Alvila G, Laranjinha I, Hofstra JM, Siezenga MA, Franco A, Arroyo D, Castellano S, Balda Manzanos S, Sosa Barrios RH, Lemahieu W, Bartelet K, Burak Dirim A, Sukru Sever M, Turkmen A, Şafak S, Hollander DAMJ, Büttner S, de Vries APJ, Meziyerh S, van der Helm D, Mallat M, Bouwsma H, Sridharan S, Petruliene K, Maloney SR, Verberk I, van der Sande FM, Christiaans MHL, Mohan Kumar N, Di Luca M, Tuğlular SZ, Kramer A, Beerenhout C, Luik PT, Tiefenthaler M, Watschinger B, Adema AY, Stepanov VA, Gandolfini I, Maggiore U, Fliedner A, Åsberg A, Mjoen G, Miyasato H, de Fijter CWH, Mongera N, Pini S, de Biase C, Kerckhoffs A, van de Logt AE, Maas R, Lebedeva O, Lopez V, Reichert LJM, Verhave J, Titov D, Parshina EV, Zanoli L, Marcantoni C, van Kempen G, van Gils-Verrij LEA, Harty JC, Meurs M, Myslak M, Battaglia Y, Lentini P, den Deurwaarder E, Stendahl M, Rychlik I, Cabezas-Reina CJ, Maria Roca A, Nauta F, Sahin İ, Goffin E, Kanaan N, Labriola L, Devresse A, Diaz-Mareque A, Coca A, de Arriba G, Meijers BKI, Naesens M, Desschans B, Tonnerlier A, Wissing KM, Dedinska I, Pessolano G, Malik S, Dounousi E, Papachristou E, Berger SP, Meijer E, Sanders JSF, Özyilmaz A, Buturović Ponikvar J, Marn Pernat A, Kovac D, Arnol M, Ekart R, Abrahams AC, Molenaar FM, van Zuilen AD, Meijvis SCA, Dolmans H, Tantisattamo E, Esposito P, Krzesinski JM, Barahira JD, Gallieni M, Martin-Moreno PL, Guglielmetti G, Guzzo G, Toapanta N, Jose Soler M, Luik AJ, van Kuijk WHM, Stikkelbroeck LWH, Hermans MMH, Rimsevicius L, Righetti M, Islam M, Heitink-Ter Braak N |
Transplantation. 2022 Mar 21. doi: 10.1097/TP.0000000000004075. pii: 00007890-900000000-95047 |
PMID: 35320154 |
Long-term Apheresis in the Management of Patients With Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation. |
Uffing A, Hullekes F, Hesselink DA, Mansur JB, Malvezzi P, de Vries APJ, Seeger H, Manfro RC, Nissaisorakarn P, Wang AX, Reindl-Schwaighofer R, Sanchez-Russo L, Cravedi P, Riella LV, Berger SP |
Kidney international reports. 2022 Mar 11. doi: 10.1016/j.ekir.2022.03.002. pii: S2468-0249(22)01208-6. pmc: PMC9171618 |
PMID: 35685308 |
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. |
Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, Ettner R, Fraser L, Goodman M, Green J, Hancock AB, Johnson TW, Karasic DH, Knudson GA, Leibowitz SF, Meyer-Bahlburg HFL, Monstrey SJ, Motmans J, Nahata L, Nieder TO, Reisner SL, Richards C, Schechter LS, Tangpricha V, Tishelman AC, Van Trotsenburg MAA, Winter S, Ducheny K, Adams NJ, Adrián TM, Allen LR, Azul D, Bagga H, Başar K, Bathory DS, Belinky JJ, Berg DR, Berli JU, Bluebond-Langner RO, Bouman MB, Bowers ML, Brassard PJ, Byrne J, Capitán L, Cargill CJ, Carswell JM, Chang SC, Chelvakumar G, Corneil T, Dalke KB, De Cuypere G, de Vries E, Den Heijer M, Devor AH, Dhejne C, D'Marco A, Edmiston EK, Edwards-Leeper L, Ehrbar R, Ehrensaft D, Eisfeld J, Elaut E, Erickson-Schroth L, Feldman JL, Fisher AD, Garcia MM, Gijs L, Green SE, Hall BP, Hardy TLD, Irwig MS, Jacobs LA, Janssen AC, Johnson K, Klink DT, Kreukels BPC, Kuper LE, Kvach EJ, Malouf MA, Massey R, Mazur T, McLachlan C, Morrison SD, Mosser SW, Neira PM, Nygren U, Oates JM, Obedin-Maliver J, Pagkalos G, Patton J, Phanuphak N, Rachlin K, Reed T, Rider GN, Ristori J, Robbins-Cherry S, Roberts SA, Rodriguez-Wallberg KA, Rosenthal SM, Sabir K, Safer JD, Scheim AI, Seal LJ, Sehoole TJ, Spencer K, St Amand C, Steensma TD, Strang JF, Taylor GB, Tilleman K, T'Sjoen GG, Vala LN, Van Mello NM, Veale JF, Vencill JA, Vincent B, Wesp LM, West MA, Arcelus J |
International journal of transgender health. 2022 Sep 6. doi: 10.1080/26895269.2022.2100644. pii: 2100644. pmc: PMC9553112 |
PMID: 36238954 |
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS). |
Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart MJ |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 30. pii: mdv249. doi: 10.1093/annonc/mdv249 |
PMID: 26026162 |
Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer. |
Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R |
Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687 |
PMID: 25759615 |
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer. |
Bartsch R, Bago-Horvath Z, Berghoff A, DeVries C, Pluschnig U, Dubsky P, Rudas M, Mader RM, Rottenfusser A, Fitzal F, Gnant M, Zielinski CC, Steger GG |
European journal of cancer (Oxford, England : 1990). 2012 Mar 27. pii: S0959-8049(12)00247-X. doi: 10.1016/j.ejca.2012.03.002 |
PMID: 22459763 |
Brain metastases free survival differs between breast cancer subtypes. |
Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, Rottenfusser A, Knauer M, Eiter H, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R |
British journal of cancer. 2012 Jan 10. pii: bjc2011597. doi: 10.1038/bjc.2011.597. pmc: PMC3273356 |
PMID: 22233926 |
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases. |
Bartsch R, Berghoff A, Pluschnig U, Bago-Horvath Z, Dubsky P, Rottenfusser A, DeVries C, Rudas M, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG |
British journal of cancer. 2011 Nov 29. pii: bjc2011531. doi: 10.1038/bjc.2011.531. pmc: PMC3251869 |
PMID: 22127284 |
Vienna international summer school on experimental and clinical oncology for medical students: an Austrian cancer education project. |
Fromm-Haidenberger S, Pohl G, Widder J, Kren G, Fitzal F, Bartsch R, de Vries J, Zielinski C, Pötter R |
Journal of cancer education : the official journal of the American Association for Cancer Education. 2010 Apr 1. doi: 10.1007/s13187-009-0011-3 |
PMID: 20082180 |
Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer. |
Bartsch R, De Vries C, Pluschnig U, Dubsky P, Bago-Horvath Z, Gampenrieder SP, Rudas M, Mader RM, Rottenfusser A, Wiltschke C, Gnant M, Zielinski CC, Steger GG |
BMC cancer. 2009 Oct 17. pii: 1471-2407-9-367. doi: 10.1186/1471-2407-9-367. pmc: PMC2770076 |
PMID: 19835621 |
Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al. |
Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart MJ |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Oct 30. pii: mdv502. doi: 10.1093/annonc/mdv502 |
PMID: 26519490 |
ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016. |
Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Jul 26. pii: mdw239. doi: 10.1093/annonc/mdw239 |
PMID: 27457308 |
Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al. |
Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart MJ, de Vries EG |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Aug 29. pii: mdw406. doi: 10.1093/annonc/mdw406 |
PMID: 27573563 |
70 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |